Updates in Biliary Atresia: Aetiology, Diagnosis and Surgery

Biliary atresia (BA) is an obliterative disease of the bile ducts affecting between 1 in 10,000–20,000 infants with a predominance in Asian countries. It is clinically heterogeneous with a number of distinct variants (e.g., isolated, Biliary Atresia Splenic Malformation syndrome, Cat-eye syndrome, c...

Full description

Saved in:
Bibliographic Details
Main Author: Mark Davenport
Format: Article
Language:English
Published: MDPI AG 2025-01-01
Series:Children
Subjects:
Online Access:https://www.mdpi.com/2227-9067/12/1/95
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832588803093561344
author Mark Davenport
author_facet Mark Davenport
author_sort Mark Davenport
collection DOAJ
description Biliary atresia (BA) is an obliterative disease of the bile ducts affecting between 1 in 10,000–20,000 infants with a predominance in Asian countries. It is clinically heterogeneous with a number of distinct variants (e.g., isolated, Biliary Atresia Splenic Malformation syndrome, Cat-eye syndrome, cystic BA, and CMV-associated BA). Facts about its aetiology are hard to encounter but might include genetic, developmental, exposure to an environmental toxin, or perinatal virus infection. However, the cholestatic injury triggers an intrahepatic fibrotic process beginning at birth and culminating in cirrhosis some months later. Affected infants present with a triad of conjugated jaundice, pale stools, and dark urine and may have hepatosplenomegaly upon examination, with later ascites coincident with the onset of progressive liver disease. Rapid, efficient, and expeditious diagnosis is essential with the initial treatment being surgical, typically with an attempt to restore the bile flow (Kasai portoenterostomy (KPE)) or primary liver transplantation (<5%) if considered futile. Failure to restore bile drainage or the onset of complications such as recurrent cholangitis, treatment-resistant varices, ascites, hepatopulmonary syndrome, and occasionally malignant change are usually managed by secondary liver transplantation. This issue summarises recent advances in the disease and points a way to future improvements in its treatment.
format Article
id doaj-art-df3f2a3f01094e20ac046958746e752f
institution Kabale University
issn 2227-9067
language English
publishDate 2025-01-01
publisher MDPI AG
record_format Article
series Children
spelling doaj-art-df3f2a3f01094e20ac046958746e752f2025-01-24T13:27:17ZengMDPI AGChildren2227-90672025-01-011219510.3390/children12010095Updates in Biliary Atresia: Aetiology, Diagnosis and SurgeryMark Davenport0Department of Paediatric Surgery, Kings College Hospital, Denmark Hill, London SE5 9RS, UKBiliary atresia (BA) is an obliterative disease of the bile ducts affecting between 1 in 10,000–20,000 infants with a predominance in Asian countries. It is clinically heterogeneous with a number of distinct variants (e.g., isolated, Biliary Atresia Splenic Malformation syndrome, Cat-eye syndrome, cystic BA, and CMV-associated BA). Facts about its aetiology are hard to encounter but might include genetic, developmental, exposure to an environmental toxin, or perinatal virus infection. However, the cholestatic injury triggers an intrahepatic fibrotic process beginning at birth and culminating in cirrhosis some months later. Affected infants present with a triad of conjugated jaundice, pale stools, and dark urine and may have hepatosplenomegaly upon examination, with later ascites coincident with the onset of progressive liver disease. Rapid, efficient, and expeditious diagnosis is essential with the initial treatment being surgical, typically with an attempt to restore the bile flow (Kasai portoenterostomy (KPE)) or primary liver transplantation (<5%) if considered futile. Failure to restore bile drainage or the onset of complications such as recurrent cholangitis, treatment-resistant varices, ascites, hepatopulmonary syndrome, and occasionally malignant change are usually managed by secondary liver transplantation. This issue summarises recent advances in the disease and points a way to future improvements in its treatment.https://www.mdpi.com/2227-9067/12/1/95biliary atresiaKasai portoenterostomyBASMadjuvant therapyliver transplantation
spellingShingle Mark Davenport
Updates in Biliary Atresia: Aetiology, Diagnosis and Surgery
Children
biliary atresia
Kasai portoenterostomy
BASM
adjuvant therapy
liver transplantation
title Updates in Biliary Atresia: Aetiology, Diagnosis and Surgery
title_full Updates in Biliary Atresia: Aetiology, Diagnosis and Surgery
title_fullStr Updates in Biliary Atresia: Aetiology, Diagnosis and Surgery
title_full_unstemmed Updates in Biliary Atresia: Aetiology, Diagnosis and Surgery
title_short Updates in Biliary Atresia: Aetiology, Diagnosis and Surgery
title_sort updates in biliary atresia aetiology diagnosis and surgery
topic biliary atresia
Kasai portoenterostomy
BASM
adjuvant therapy
liver transplantation
url https://www.mdpi.com/2227-9067/12/1/95
work_keys_str_mv AT markdavenport updatesinbiliaryatresiaaetiologydiagnosisandsurgery